← peptides typeshit

GLP-1 obesity drug sales value rose 72% in September 2026 while units fell 10%

New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.

See it on Facebook

Recap by typeshit. Post by Facebook on Facebook.